These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 11287761

  • 1. Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study.
    Movilli E, Zani R, Carli O, Sangalli L, Pola A, Camerini C, Scolari F, Cancarini GC, Maiorca R.
    Nephron; 2001 Mar; 87(3):257-62. PubMed ID: 11287761
    [Abstract] [Full Text] [Related]

  • 2. Effect of oral sodium bicarbonate supplementation on interdialytic weight gain, plasma sodium concentrations and predialysis blood pressure in hemodialysis patients.
    Movilli E, Gaggia P, Camerini C, Brunori G, Vizzardi V, Cancarini G.
    Blood Purif; 2005 Mar; 23(5):379-83. PubMed ID: 16088106
    [Abstract] [Full Text] [Related]

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 4. The role of oral sodium bicarbonate supplementation in maintaining acid-base balance and its influence on the cardiovascular system in chronic hemodialysis patients - results of a prospective study.
    Voiculeț C, Zară O, Bogeanu C, Văcăroiu I, Aron G.
    J Med Life; 2016 Nov; 9(4):449-454. PubMed ID: 27928454
    [Abstract] [Full Text] [Related]

  • 5. Acute effects of repetitive hemodialysis on circulating immunoreactive parathyroid hormone levels in uremic patients undergoing vitamin D (calcitriol) therapy.
    Bellazzi R, Romanini D, Bacchella L, Nai M, Aprile C, Santagostino M, De Vincenzi A.
    Nephron; 1991 Nov; 57(3):273-82. PubMed ID: 2017266
    [Abstract] [Full Text] [Related]

  • 6. Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study.
    Movilli E, Zani R, Carli O, Sangalli L, Pola A, Camerini C, Cancarini GC, Scolari F, Feller P, Maiorca R.
    Nephrol Dial Transplant; 1998 Jul; 13(7):1719-22. PubMed ID: 9681718
    [Abstract] [Full Text] [Related]

  • 7. Long-term effect of oral calcitriol single weekly pulse in CAPD and in HD.
    Romanini D, Gazo A, Bellazzi R, de Vincenzi A, Nai M, Santagostino M.
    Adv Perit Dial; 1994 Jul; 10():267-9. PubMed ID: 7999842
    [Abstract] [Full Text] [Related]

  • 8. Long-term management of sevelamer hydrochloride-induced metabolic acidosis aggravation and hyperkalemia in hemodialysis patients.
    Sonikian M, Metaxaki P, Iliopoulos A, Marioli S, Vlassopoulos D.
    Ren Fail; 2006 Jul; 28(5):411-8. PubMed ID: 16825091
    [Abstract] [Full Text] [Related]

  • 9. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.
    Lu KC, Lin SH, Yu FC, Chyr SH, Shieh SD.
    Miner Electrolyte Metab; 1995 Jul; 21(6):398-402. PubMed ID: 8592483
    [Abstract] [Full Text] [Related]

  • 10. Serum ionized calcium, parathyroid hormone and phosphate in uremic patients during and between hemodialysis.
    Rudnicki M, Frølich A, Haaber A, Tvedegaard E, Thode J.
    Clin Nephrol; 1993 Oct; 40(4):225-9. PubMed ID: 8261680
    [Abstract] [Full Text] [Related]

  • 11. Assessment of acute parathyroid responsiveness to high calcium dialysate in uremic patients.
    Melan A, Schiffl H, Held E, Horn K.
    Int J Artif Organs; 1993 Oct; 16(10):711-5. PubMed ID: 8125617
    [Abstract] [Full Text] [Related]

  • 12. [Effect of calcitriol on secondary hyperparathyroidism].
    Xu H, Zhang J, Cheng X, Zhou Q.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 38(9):920-4. PubMed ID: 24071691
    [Abstract] [Full Text] [Related]

  • 13. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F, Corradi B, Imbasciati E.
    Adv Perit Dial; 1996 Sep; 12():239-44. PubMed ID: 8865912
    [Abstract] [Full Text] [Related]

  • 14. Sevelamer hydrochloride improves hyperphosphatemia in hemodialysis patients with low bone turnover rate and low intact parathyroid hormone levels.
    Kokuho T, Toya Y, Kawaguchi Y, Tamura K, Iwatsubo K, Dobashi Y, Nakazawa A, Takeda H, Iwatsubo M, Hirawa N, Yasuda G, Ohnishi T, Umemura S.
    Ther Apher Dial; 2007 Dec; 11(6):442-8. PubMed ID: 18028171
    [Abstract] [Full Text] [Related]

  • 15. Correction of metabolic acidosis and its effect on albumin in chronic hemodialysis patients.
    Brady JP, Hasbargen JA.
    Am J Kidney Dis; 1998 Jan; 31(1):35-40. PubMed ID: 9428449
    [Abstract] [Full Text] [Related]

  • 16. Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients.
    Movilli E, Viola BF, Camerini C, Mazzola G, Cancarini GC.
    J Ren Nutr; 2009 Mar; 19(2):172-7. PubMed ID: 19218045
    [Abstract] [Full Text] [Related]

  • 17. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study.
    Gu Y, Ding F, Chen N, Mei CL, Qian JQ, Wang XY, Shi W, Hou FF, Li XW, Wang M, Chen YP.
    Ren Fail; 2005 Mar; 27(2):205-12. PubMed ID: 15807187
    [Abstract] [Full Text] [Related]

  • 18. Sevelamer worsens metabolic acidosis in hemodialysis patients.
    De Santo NG, Frangiosa A, Anastasio P, Marino A, Correale G, Perna A, Di Stazio E, Stellato D, Santoro D, Di Meglio E, Iacono G, Ciacci C, Savica V, Cirillo M.
    J Nephrol; 2006 Mar; 19 Suppl 9():S108-14. PubMed ID: 16736432
    [Abstract] [Full Text] [Related]

  • 19. Correction of metabolic acidosis in hemodialysis: consequences on serum leptin and mineral metabolism.
    Bales AM, Moysés RM, dos Reis LM, Graciolli FG, Hung J, Martins Castro MC, Elias RM.
    Int Urol Nephrol; 2015 Jan; 47(1):177-82. PubMed ID: 25252843
    [Abstract] [Full Text] [Related]

  • 20. Rapid correction of metabolic acidosis in chronic renal failure: effect on parathyroid hormone activity.
    Lu KC, Shieh SD, Li BL, Chu P, Jan SY, Lin YF.
    Nephron; 1994 Jan; 67(4):419-24. PubMed ID: 7969674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.